Exact Mass: 384.2062
Exact Mass Matches: 384.2062
Found 274 metabolites which its exact mass value is equals to given mass value 384.2062,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Rhynchophylline
Rhynchophylline is a member of indolizines. It has a role as a metabolite. Rhynchophylline is a natural product found in Uncaria tomentosa, Mitragyna inermis, and other organisms with data available. See also: Cats Claw (part of). A natural product found in Uncaria macrophylla. Annotation level-1 Rhyncholphylline is an alkaloid compound isolated from Uncaria rhynchophyllum. It has high biological activity and is widely used in anti-inflammatory, neuroprotective and other research. Rhyncholphylline is an alkaloid compound isolated from Uncaria rhynchophyllum. It has high biological activity and is widely used in anti-inflammatory, neuroprotective and other research.
IsoRhy
Isorhynchophylline is a member of indolizines. It has a role as a metabolite. Isorhynchophylline is a natural product found in Uncaria tomentosa, Mitragyna inermis, and other organisms with data available. See also: Cats Claw (part of). A natural product found in Uncaria macrophylla. Isorhynchophylline is an alkaloid compound isolated from Uncaria. It can lower blood pressure, relax blood vessels, and protect nerves from damage caused by local ischemia. Isorhynchophylline is an alkaloid compound isolated from Uncaria. It can lower blood pressure, relax blood vessels, and protect nerves from damage caused by local ischemia.
16-Methoxy-2,3-dihydro-3-hydroxytabersonine
Cinnzeylanol
Constituent of the dried bark of Cinnamomum zeylanicum (cinnamon) and of Cinnamomum cassia (Chinese cinnamon) [CCD]. Cinnzeylanol is found in chinese cinnamon, ceylon cinnamon, and herbs and spices. Cinnzeylanol is found in ceylan cinnamon. Cinnzeylanol is a constituent of the dried bark of Cinnamomum zeylanicum (cinnamon) and of Cinnamomum cassia (Chinese cinnamon)
Bortezomib
Bortezomib (originally PS-341 and marketed as Velcade by Millennium Pharmaceuticals) is the first therapeutic proteasome inhibitor to be tested in humans. It is approved in the U.S. for treating relapsed multiple myeloma and mantle cell lymphoma. In multiple myeloma, complete clinical responses have been obtained in patients with otherwise refractory or rapidly advancing disease. L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01X - Other antineoplastic agents > L01XG - Proteasome inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2160 - Proteasome Inhibitor D000970 - Antineoplastic Agents C471 - Enzyme Inhibitor
20-Trihydroxy-leukotriene-B4
20-trihydroxy-leukotriene-B4 is the metabolite of lipid omega-oxidation of leukotriene B4 (LTB4). LTB4 is the major metabolite in neutrophil polymorphonuclear leukocytes. Omega-oxidation is the major pathway for the catabolism of leukotriene B4 in human polymorphonuclear leukocytes. Leukotrienes are metabolites of arachidonic acid derived from the action of 5-LO (5-lipoxygenase). The immediate product of 5-LO is LTA4 (leukotriene A4), which is enzymatically converted into either LTB4 (leukotriene B4) by LTA4 hydrolase or LTC4 (leukotriene C4) by LTC4 synthase. The regulation of leukotriene production occurs at various levels, including expression of 5-LO, translocation of 5-LO to the perinuclear region, and phosphorylation to either enhance or inhibit the activity of 5-LO. Biologically active LTB4 is metabolized by omega-oxidation carried out by specific cytochrome P450s (CYP4F) followed by beta-oxidation from the omega-carboxy position and after CoA ester formation (PMID: 7649996, 17623009, 2853166, 6088485). Leukotrienes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways. 20-trihydroxy-leukotriene-B4 is the metabolite of lipid omega-oxidation of leukotriene B4 (LTB4). LTB4 is the major metabolite in neutrophil polymorphonuclear leukocytes. Omega-oxidation is the major pathway for the catabolism of leukotriene B4 in human polymorphonuclear leukocytes. Leukotrienes are metabolites of arachidonic acid derived from the action of 5-LO (5-lipoxygenase). The immediate product of 5-LO is LTA4 (leukotriene A4), which is enzymatically converted into either LTB4 (leukotriene B4) by LTA4 hydrolase or LTC4 (leukotriene C4) by LTC4 synthase. The regulation of leukotriene production occurs at various levels, including expression of 5-LO, translocation of 5-LO to the perinuclear region and phosphorylation to either enhance or inhibit the activity of 5-LO. Biologically active LTB4 is metabolized by w-oxidation carried out by specific cytochrome P450s (CYP4F) followed by beta-oxidation from the w-carboxy position and after CoA ester formation. (PMID: 7649996, 17623009, 2853166, 6088485)
repaglinide aromatic amine
repaglinide aromatic amine is a metabolite of repaglinide. Repaglinide is for the treatment of type II diabetes. It is supplied by Novo Nordisk. It is sold in Japan by Dainippon Sumitomo Pharma. Repaglinide belongs to the meglitinide class of blood glucose-lowering drugs. (Wikipedia)
Isorhynchophylline
Corynoxine
Corynoxine is a member of indolizines. It has a role as a metabolite. Corynoxine is a natural product found in Mitragyna speciosa, Uncaria attenuata, and Uncaria macrophylla with data available. A natural product found in Uncaria macrophylla. Corynoxine, a tetracyclic oxindole alkaloid, is isolated from the hooks of Uncaria rhynchophylla. Corynoxine is a natural autophagy enhancer that promotes the clearance of alpha-synuclein via Akt/mTOR pathway[1]. Corynoxine, a tetracyclic oxindole alkaloid, is isolated from the hooks of Uncaria rhynchophylla. Corynoxine is a natural autophagy enhancer that promotes the clearance of alpha-synuclein via Akt/mTOR pathway[1]. Corynoxine B is a natural compound of indole alkaloids and a beclin-1-dependent autophagy inducer. Corynoxine B is a natural compound of indole alkaloids and a beclin-1-dependent autophagy inducer.
Corynoxine B
A natural product found in Uncaria macrophylla. Corynoxine B is a member of indolizines. It has a role as a metabolite. Corynoxine B is a natural product found in Mitragyna speciosa and Uncaria macrophylla with data available. Corynoxine B is a natural compound of indole alkaloids and a beclin-1-dependent autophagy inducer. Corynoxine B is a natural compound of indole alkaloids and a beclin-1-dependent autophagy inducer.
(1alpha,2beta,3beta.5beta.6beta,7alpha,10alpha,14beta,16alpha)-2,3-Epoxy-5,6,7,10,14,16-grayanotoxanexol|Pieristoxin H|pieritoxin H
18-hydroxy-17-methoxy-yohimbane-16-carboxylic acid methyl ester|Deserpidinsaeure-methylester|Deserpidsaeure-methylester|Deserpinsaeure-methylester|ent-18alpha-Hydroxy-17beta-methoxy-15beta-yohimban-16alpha-carbonsaeure-methylester|ent-18alpha-hydroxy-17beta-methoxy-15beta-yohimban-16alpha-carboxylic acid methyl ester|Methyl deserpidate
(16E)-9-Hydroxy-17-methoxy-coryn-16-en-16-carbonsaeure-methylester|(16E)-9-hydroxy-17-methoxy-coryn-16-ene-16-carboxylic acid methyl ester|Gambirine
19-hydroxy-13-methoxy-ibogamine-18-carboxylic acid methyl ester|19-Hydroxy-isovoacangin|3-R/S-hydroxy-isovoacangine
(16S,19E)-N1-(hydroxymethyl)isositsirikine|methyl (2S)-2-[(2R,3E,12bS)-3-ethylidene-1,2,3,4,6,7,12,12b-octahydro-12-(hydroxymethyl)indolo[2,3-a]quinolizin-2-yl]-3-hydroxypropanoate
12-Methoxy-vincamin|14-hydroxy-12-methoxy-14,15-dihydro-eburnamenine-14-carboxylic acid methyl ester|Methoxy-12-vincamin
3alpha-(2,3-epoxy-2-methylbutyryloxy)-4alpha,7alpha,11-trihydroxyeudesman-8-one
N(a)-Acetyl-11-methoxystrychnosplendine|Na-Acetyl-11-methoxystrychnosplendine
Lehualide H
A member of the class of 2-pyranones that is 2H-pyran-2-one substituted by methoxy groups at positions 3 and 4, a methyl group at position 5 and a 10-(acetylsulfanyl)decyl group at position 6. Isolated from the marine sponge of the genus Plakortis, it exhibits cytotoxicity against human promyeloid leukemic HL-60 cells.
Methyl 11-methoxy-19-methyloxayohimban-16-carboxylate #
(6R,11S,13S)-6,11,13-trihydroxy-2,3-seco-14-labden-2,8-olid-3-oic acid|rhizophorin A
(19R)-1-acetyl-17,19-epoxy-11-methoxy-curan-12-ol|12-hydroxy-11-methoxy-spermostrychnine|12-Hydroxy-11-methoxyspermostrychnin
jerantinine E
An indole alkaloid that is the 14-15-dihydro derivative of jerantinine A. Isolated from Tabernaemontana corymbosa, it exhibits cytotoxicity against human KB cells.
rhyncophylline
Rhyncholphylline is an alkaloid compound isolated from Uncaria rhynchophyllum. It has high biological activity and is widely used in anti-inflammatory, neuroprotective and other research. Rhyncholphylline is an alkaloid compound isolated from Uncaria rhynchophyllum. It has high biological activity and is widely used in anti-inflammatory, neuroprotective and other research.
Mitrinermine
Rhyncholphylline is an alkaloid compound isolated from Uncaria rhynchophyllum. It has high biological activity and is widely used in anti-inflammatory, neuroprotective and other research. Rhyncholphylline is an alkaloid compound isolated from Uncaria rhynchophyllum. It has high biological activity and is widely used in anti-inflammatory, neuroprotective and other research.
Ala Pro Pro Thr
Ala Pro Thr Pro
Ala Thr Pro Pro
Pro Ala Pro Thr
Pro Ala Thr Pro
Pro Pro Ala Thr
Pro Pro Thr Ala
Pro Thr Ala Pro
Pro Thr Pro Ala
Thr Ala Pro Pro
Thr Pro Ala Pro
Thr Pro Pro Ala
Bortezomib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01X - Other antineoplastic agents > L01XG - Proteasome inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2160 - Proteasome Inhibitor D000970 - Antineoplastic Agents C471 - Enzyme Inhibitor
Cinnzeylanol
Berkeleylactone E
Berkeleylactone K
((R)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid
1-BOC-4-(CARBOXY-NAPHTHALEN-2-YL-METHYL)-[1,4]DIAZEPANE
(3-BOC-AMINO-AZETIDIN-1-YL)-PYRIDIN-3-YL-ACETICACID
TERT-BUTYL 4-((3-(CYCLOPROPYLAMINO)QUINOXALIN-2-YL)OXY)PIPERIDINE-1-CARBOXYLATE
methyl 2-(2-(benzyloxycarbonylamino)-(1,3-d6-propan)-2-yl)-5-hydroxy-1-(methyl-d3)-6-oxo-1,6-dihydropyrimidine-4-carboxylate
Boronic acid, B-[(1S)-3-Methyl-1-[[(2R)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)aMino]propyl]aMino]butyl]-
(2E,8R)-8-({3,6-dideoxy-4-O-[(2E)-2-methylbut-2-enoyl]-alpha-L-arabino-hexopyranosyl}oxy)non-2-enoic acid
3-(5-{[4-(Aminomethyl)piperidin-1-Yl]methyl}-1h-Indol-2-Yl)-1h-Indazole-6-Carbonitrile
Methyl 17-(1-hydroxyethyl)-7-methoxy-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraene-1-carboxylate
methyl (1R,10S,11R,12R,19R)-12-ethyl-10,11-dihydroxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate
[4-(2,3-Dimethylphenyl)-1-piperazinyl]-(3,4,5-trimethoxyphenyl)methanone
(2S)-2-[[(2S)-2-amino-1-oxopropyl]amino]-3-methyl-N-[(2S)-1-(1-naphthalenylamino)-1-oxopropan-2-yl]butanamide
2-[(2-amino-1-oxopropyl)amino]-3-methyl-N-[1-(1-naphthalenylamino)-1-oxopropan-2-yl]butanamide
(1S,5R)-3-[(3-fluorophenyl)methyl]-7-[4-[(E)-2-phenylethenyl]phenyl]-3,6-diazabicyclo[3.1.1]heptane
(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
13,14-dihydro-15-oxo-20-carboxy-PGF2alpha
A member of the class of prostaglandins Falpha that is 15-oxo-prostaglandin F2alpha in which the methyl group has been oxidised to the corresponding carboxylic acid and in which the double bond at positions 13-14 has been reduced to a single bond.
(5S,6Z,8E,10E,12R,14Z)-5,12,20,20,20-pentahydroxyicosa-6,8,10,14-tetraenoic acid
6-[4-[1-(2-hydroxycyclohexyl)-2H-tetrazol-1-ium-5-yl]butoxy]-1H-quinolin-2-one
6-[4-[1-(4-hydroxycyclohexyl)-2H-tetrazol-1-ium-5-yl]butoxy]-1H-quinolin-2-one
2-[Hydroxy-(2-hydroxy-3-octanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium
Methyl (1S,10R,12R,19S)-12-ethyl-10-hydroxy-5-methoxy-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2(7),3,5,13-tetraene-10-carboxylate
[3-Methyl-1-[[1-oxo-2-[[oxo(2-pyrazinyl)methyl]amino]-3-phenylpropyl]amino]butyl]boronic acid
AR-M 1000390 (hydrochloride)
AR-M 1000390 hydrochloride is an exceptionally selective, potent δ opioid receptor agonist with an EC50 of 7.2±0.9 nM for δ agonist potency.
methyl (1s,15r,17s,18s)-17-[(1s)-1-hydroxyethyl]-7-methoxy-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraene-1-carboxylate
methyl 6-methoxy-16-methyl-17-oxa-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8-tetraene-19-carboxylate
methyl (2z)-2-[(3s,6's,7'r,8'ar)-6'-ethyl-2-hydroxy-3',5',6',7',8',8'a-hexahydro-2'h-spiro[indole-3,1'-indolizin]-7'-yl]-3-methoxyprop-2-enoate
methyl 5-{8-[6-(methoxycarbonyl)pyridin-3-yl]octyl}pyridine-2-carboxylate
methyl (1s,15s,18r,19s,20r)-18-hydroxy-8-methoxy-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8-tetraene-19-carboxylate
methyl (1s,15s,17s,18s)-17-[(1r)-1-hydroxyethyl]-7-methoxy-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraene-1-carboxylate
methyl (1r,15s,18s,19s,20r)-18-hydroxy-6-methoxy-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8-tetraene-19-carboxylate
methyl 17-hydroxy-6-methoxy-10,13-diazapentacyclo[11.8.0.0³,¹¹.0⁴,⁹.0¹⁵,²⁰]henicosa-3(11),4,6,8-tetraene-16-carboxylate
methyl (2e)-2-[(2s,3r,12bs)-3-ethyl-9-hydroxy-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-2-yl]-3-methoxyprop-2-enoate
(1s,2s,4ar,8ar)-1-hydroxy-7-(2-hydroxypropan-2-yl)-1,4a-dimethyl-6-oxo-3,4,5,8a-tetrahydro-2h-naphthalen-2-yl (2s,3s)-2,3-dihydroxy-2-methylbutanoate
methyl (2e)-2-[(6's,7's)-6'-ethyl-2-hydroxy-3',5',6',7',8',8'a-hexahydro-2'h-spiro[indole-3,1'-indolizin]-7'-yl]-3-methoxyprop-2-enoate
methyl (1s,15s,18r,19r,20s)-18-hydroxy-8-methoxy-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8-tetraene-19-carboxylate
hydroxy(3-hydroxy-5-oxo-4-tetradecanoyl-2h-furan-2-yl)acetic acid
methyl (1s,15s,18r,19s,20s)-18-hydroxy-8-methoxy-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8-tetraene-19-carboxylate
methyl (1s,9r,16r,18r,21s)-18-hydroxy-4-methoxy-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7-triene-18-carboxylate
methyl (1s,15r,18s,19r,20s)-18-hydroxy-7-methoxy-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8-tetraene-19-carboxylate
11-(acetyloxy)-12-hydroxy-7-methoxy-2,2,4,9-tetramethyl-6-oxatricyclo[6.3.1.0⁴,¹²]dodecan-3-yl acetate
8-hydroxy-2,4,7,8a-tetramethyl-6-oxo-hexahydropyrano[3,2-b]pyran-3-yl 4-hydroxyoct-2-enoate
3-[(1s,12s,13r,14r)-13-(hydroxymethyl)-3,16-dimethyl-3,16-diazatetracyclo[10.3.1.0²,¹⁰.0⁴,⁹]hexadeca-2(10),4,6,8-tetraen-14-yl]-4-oxopentanoic acid
methyl (2e)-2-[(6'r,7's,8'as)-6'-ethyl-2-hydroxy-3',5',6',7',8',8'a-hexahydro-2'h-spiro[indole-3,1'-indolizin]-7'-yl]-3-methoxyprop-2-enoate
(1r,3r,4s,7s,8s,9r,11s,12s)-11-(acetyloxy)-12-hydroxy-7-methoxy-2,2,4,9-tetramethyl-6-oxatricyclo[6.3.1.0⁴,¹²]dodecan-3-yl acetate
methyl (1s,15s,18r,19s,20r)-18-hydroxy-6-methoxy-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8-tetraene-19-carboxylate
10-methoxycathafolinen(4)-oxide
{"Ingredient_id": "HBIN000166","Ingredient_name": "10-methoxycathafolinen(4)-oxide","Alias": "NA","Ingredient_formula": "C22H28N2O4","Ingredient_Smile": "CC=C1C[N+]2(CCC34C(C1CC2C3N(C5=C4C=C(C=C5)OC)C)C(=O)OC)[O-]","Ingredient_weight": "384.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "13872","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101727479","DrugBank_id": "NA"}
11-methoxyhumantenine
{"Ingredient_id": "HBIN000467","Ingredient_name": "11-methoxyhumantenine","Alias": "Humantenine, 11-methoxy-; 93914-74-0; N-Methylhumantenirine","Ingredient_formula": "C22H28N2O4","Ingredient_Smile": "CC=C1CN(C2CC3(C4CC1C2CO4)C5=C(C=C(C=C5)OC)N(C3=O)OC)C","Ingredient_weight": "384.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT16506","TCMID_id": "13941","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "44583832","DrugBank_id": "NA"}
19-epivoacristine
{"Ingredient_id": "HBIN002184","Ingredient_name": "19-epivoacristine","Alias": "19-epi-voacristine","Ingredient_formula": "C22H28N2O4","Ingredient_Smile": "CC(C1CC2CC3(C1N(C2)CCC4=C3NC5=C4C=C(C=C5)OC)C(=O)OC)O","Ingredient_weight": "384.47","OB_score": "NA","CAS_id": "6883-77-8","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9255;19375","PubChem_id": "56842093","DrugBank_id": "NA"}
9-methoxy-3-epi-α-yohimbine
{"Ingredient_id": "HBIN014126","Ingredient_name": "9-methoxy-3-epi-\u03b1-yohimbine","Alias": "NA","Ingredient_formula": "C22H28N2O4","Ingredient_Smile": "COC1=CC=CC2=C1C3=C(N2)C4CC5C(CCC(C5C(=O)OC)O)CN4CC3","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14101","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
alstovenine
{"Ingredient_id": "HBIN015778","Ingredient_name": "alstovenine","Alias": "NA","Ingredient_formula": "C22H28N2O4","Ingredient_Smile": "COC1=CC=CC2=C1C3=C(N2)C4CC5C(CCC(C5C(=O)OC)O)CN4CC3","Ingredient_weight": "384.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1007","TCMSP_id": "NA","TCM_ID_id": "6852;21529;21530","PubChem_id": "199742","DrugBank_id": "NA"}
